ROBERT KRANCE to Drug Evaluation
This is a "connection" page, showing publications ROBERT KRANCE has written about Drug Evaluation.
Connection Strength
0.037
-
Phase I evaluation of diaziquone in childhood cancer. A Pediatric Oncology Group study. Invest New Drugs. 1990 May; 8(2):167-70.
Score: 0.020
-
Biochemical interactions between methotrexate and 1-beta-D-arabinofuranosylcytosine in hematopoietic cells of children: a Pediatric Oncology Group study. Cancer Chemother Pharmacol. 1990; 27(1):60-6.
Score: 0.005
-
Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T-cell leukemia. Cancer. 1987 Nov 15; 60(10):2366-71.
Score: 0.004
-
Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood. 1987 Apr; 69(4):1015-20.
Score: 0.004
-
Novantrone for childhood malignant solid tumors. A pediatric oncology group phase II study. Invest New Drugs. 1986; 4(1):43-8.
Score: 0.004